Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (191-200 of 489) with videos related to

Pageof 49
Sort By:
The Journal of Urology|December 23, 2018
Re: Sustained-Release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical StudySam S Chang
The Journal of Urology|November 12, 2019
Re: A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 InhibitorSam S Chang
The Journal of Urology|November 16, 2016
Re: HER2 as a Target in Invasive Urothelial CarcinomaSam S Chang
The Journal of Urology|March 30, 2019
Re: Contemporary Treatment Patterns and Outcomes of Sarcomatoid Bladder CancerSam S Chang
The Journal of Urology|May 20, 2015
Re: Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicitySam S Chang
The Journal of Urology|August 2, 2016
Re: Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted TherapySam S Chang
The Journal of Urology|June 20, 2015
Re: Evidenced-Based Clinical Practice Guideline for Upper Tract Urothelial Carcinoma (summary-Japanese Urological Association, 2014 edition)Sam S Chang
The Journal of Urology|April 10, 2020
Re: Bladder Preservation with Twice-a-Day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialSam S Chang
The Journal of Urology|April 10, 2020
Re: Cost Considerations for Systemic Therapy for Patients with Advanced Genitourinary MalignanciesSam S Chang
Current Opinion in Investigational Drugs (London, England : 2000)|July 10, 2004
Monoclonal antibodies and prostate-specific membrane antigenSam S Chang
Pageof 49

Showing results (191-200 of 489) with videos related to

Sort By:
Pageof 49
The Journal of Urology|December 23, 2018
Re: Sustained-Release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical StudySam S Chang
The Journal of Urology|November 12, 2019
Re: A Multifactorial Model of T Cell Expansion and Durable Clinical Benefit in Response to a PD-L1 InhibitorSam S Chang
The Journal of Urology|November 16, 2016
Re: HER2 as a Target in Invasive Urothelial CarcinomaSam S Chang
The Journal of Urology|March 30, 2019
Re: Contemporary Treatment Patterns and Outcomes of Sarcomatoid Bladder CancerSam S Chang
The Journal of Urology|May 20, 2015
Re: Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicitySam S Chang
The Journal of Urology|August 2, 2016
Re: Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted TherapySam S Chang
The Journal of Urology|June 20, 2015
Re: Evidenced-Based Clinical Practice Guideline for Upper Tract Urothelial Carcinoma (summary-Japanese Urological Association, 2014 edition)Sam S Chang
The Journal of Urology|April 10, 2020
Re: Bladder Preservation with Twice-a-Day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialSam S Chang
The Journal of Urology|April 10, 2020
Re: Cost Considerations for Systemic Therapy for Patients with Advanced Genitourinary MalignanciesSam S Chang
Current Opinion in Investigational Drugs (London, England : 2000)|July 10, 2004
Monoclonal antibodies and prostate-specific membrane antigenSam S Chang
Pageof 49